Harrow Health, Inc. (HROW) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -8.99M | 8.41M | 16.59M | -803K | 19.67M | -17.78M | 2.95M | -2.75M | -4.63M | 8.7M | -1.21M | 4.57M |
| Operating CF Margin % | -20.34% | 9.44% | 23.16% | -1.26% | 41.12% | -26.6% | 5.99% | -5.61% | -13.38% | 23.92% | -3.53% | 13.64% |
| Operating CF Growth % | -145.72% | 147.31% | 462.11% | 70.76% | 524.98% | -304.45% | 344.29% | -160.14% | 43.66% | 334.27% | -194.63% | -6.05% |
| Net Income | -27.6M | 6.63M | 1.02M | 5M | -17.78M | 6.78M | -4.22M | -6.47M | -13.56M | -9.15M | -4.39M | -4.23M |
| Depreciation & Amortization | 5.58M | 4.97M | 4.9M | 6.19M | 4.91M | 4.81M | 3.74M | 3.2M | 4.16M | 3.07M | 3.17M | 3.42M |
| Stock-Based Compensation | 3.84M | 3.8M | 3.27M | 875K | 4.56M | 4.79M | 4.38M | 4.27M | 4.17M | 4.17M | 4.48M | 5.41M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 623K | 0 | 0 | 288K | 0 |
| Other Non-Cash Items | 448K | 4.65M | 9.09M | -12.74M | 1.39M | 970K | 3.69M | 2.89M | -7.74M | 1.9M | -342K | 1.58M |
| Working Capital Changes | 8.74M | -11.63M | -1.69M | -125K | 26.59M | -35.13M | -4.65M | -7.25M | 8.35M | 8.7M | -4.41M | -1.62M |
| Change in Receivables | 9.83M | -33.22M | 1.01M | -1.99M | 39.2M | -62.78M | -1.82M | -24.03M | 8.4M | -18.06M | -249K | -6.16M |
| Change in Inventory | -2.97M | -689K | -1.28M | -836K | -14K | -546K | -731K | 1.39M | 57K | -1.94M | -369K | 538K |
| Change in Payables | 3.38M | 22.44M | -3.04M | 0 | -11.1M | 31.07M | 0 | 12.3M | 0 | 30.21M | -2M | 3.8M |
| Cash from Investing | -18.2M | -4.73M | -225K | -293K | -212K | -37.56M | -597K | 5.1M | -110K | -203K | -20.13M | -1.25M |
| Capital Expenditures | -203K | -506K | -225K | -166K | -170K | -555K | -604K | -407K | -92K | -194K | -520K | -250K |
| CapEx % of Revenue | 0.46% | 0.57% | 0.31% | 0.26% | 0.36% | 0.83% | 1.23% | 0.83% | 0.27% | 0.53% | 1.52% | 0.75% |
| Acquisitions | 0 | -4.36M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 134K | 0 | -127K | -42K | -37.01M | 7K | 0 | -18K | -9K | -19.61M | -999K |
| Cash from Financing | 48.91M | -5.04M | 4.96M | -12.67M | 23K | 29.98M | -721K | 73K | -809K | -18K | 64.19M | 189K |
| Debt Issued (Net) | 48.89M | -48K | 11.89M | 0 | 0 | 29.78M | 0 | 0 | 0 | 0 | 11.97M | 0 |
| Equity Issued (Net) | 25K | 180K | 162K | -12.77M | 0 | 0 | -1.21M | 173K | -1.16M | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | -12.77M | 0 | 0 | -1.21M | 0 | -1.16M | 0 | 0 | 0 |
| Other Financing | 0 | -5.18M | -7.09M | 102K | 23K | 205K | 484K | -100K | 348K | -18K | 52.23M | 189K |
| Net Change in Cash | 21.72M | -1.36M | 21.33M | -13.76M | 19.48M | -25.35M | 1.63M | 2.43M | -5.55M | 8.47M | 42.86M | 3.51M |
| Free Cash Flow | -9.19M | 8.07M | 16.38M | -969K | 19.46M | -55.34M | 2.35M | -3.09M | -4.72M | 8.49M | -21.34M | 3.32M |
| FCF Margin % | -20.78% | 9.06% | 22.86% | -1.52% | 40.68% | -82.8% | 4.76% | -6.31% | -13.65% | 23.36% | -62.28% | 9.91% |
| FCF Growth % | -147.21% | 114.58% | 597.83% | 68.64% | 512.2% | -751.58% | 111% | -193.16% | 45.81% | 285.03% | -1342.8% | -27.89% |
| FCF per Share | -0.25 | 0.22 | 0.42 | -0.02 | 0.54 | -1.55 | 0.07 | -0.09 | -0.13 | 0.24 | -0.62 | 0.11 |
| FCF Conversion (FCF/Net Income) | 0.33x | 1.27x | 16.26x | -0.16x | -1.11x | -2.62x | -0.70x | 0.42x | 0.34x | -0.95x | 0.28x | -1.08x |
| Interest Paid | 0 | 0 | 0 | 5.79M | 6.39M | 5.04M | 5.24M | 0 | 5.34M | 6.61M | 4.2M | 4.71M |
| Taxes Paid | 0 | 0 | 0 | 0 | 38K | 374K | 0 | 0 | 0 | 0 | -4K | 4K |